<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="preprint">
<?all-math-mml yes?>
<?use-mml?>
<?origin ukpmcpa?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">bioRxiv</journal-id>
<journal-title-group>
<journal-title>bioRxiv : the preprint server for biology</journal-title>
</journal-title-group>
<issn pub-type="ppub"/>
</journal-meta>
<article-meta>
<article-id pub-id-type="manuscript">EMS94924</article-id>
<article-id pub-id-type="doi">10.1101/2020.09.09.289892</article-id>
<article-id pub-id-type="archive">PPR212354</article-id>
<article-version article-version-type="publisher-id">1</article-version>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Initial insights into the genetic epidemiology of SARS-CoV-2 isolates from Kerala suggest local spread from limited introductions</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Radhakrishnan</surname>
<given-names>Chandni</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="fn" rid="FN1">$</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Divakar</surname>
<given-names>Mohit Kumar</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="fn" rid="FN1">$</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jain</surname>
<given-names>Abhinav</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="fn" rid="FN1">$</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Viswanathan</surname>
<given-names>Prasanth</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bhoyar</surname>
<given-names>Rahul C.</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jolly</surname>
<given-names>Bani</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Imran</surname>
<given-names>Mohamed</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sharma</surname>
<given-names>Disha</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rophina</surname>
<given-names>Mercy</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ranjan</surname>
<given-names>Gyan</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jose</surname>
<given-names>Beena Philomina</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Raman</surname>
<given-names>Rajendran Vadukkoot</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kesavan</surname>
<given-names>Thulaseedharan Nallaveettil</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>George</surname>
<given-names>Kalpana</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mathew</surname>
<given-names>Sheela</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Poovullathil</surname>
<given-names>Jayesh Kumar</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Govindan</surname>
<given-names>Sajeeth Kumar Keeriyatt</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nair</surname>
<given-names>Priyanka Raveendranadhan</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Vadekkandiyil</surname>
<given-names>Shameer</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gladson</surname>
<given-names>Vineeth</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mohan</surname>
<given-names>Midhun</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Parambath</surname>
<given-names>Fairoz Cheriyalingal</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mangla</surname>
<given-names>Mohit</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shamnath</surname>
<given-names>Afra</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<collab>Indian CoV2 Genomics &amp; Genetic Epidemiology (IndiCovGEN) Consortium</collab>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sivasubbu</surname>
<given-names>Sridhar</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="corresp" rid="CR1">#</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Scaria</surname>
<given-names>Vinod</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="corresp" rid="CR1">#</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Government Medical College, Kozhikode, Medical College PO, Kozhikode Kerala, INDIA</aff>
<aff id="A2">
<label>2</label>CSIR Institute of Genomics and Integrative Biology (CSIR-IGIB), Mathura Road, Delhi, INDIA</aff>
<aff id="A3">
<label>3</label>Academy of Scientific and Innovative Research (AcSIR), Ghaziabad-201002, INDIA</aff>
<author-notes>
<fn id="FN1" fn-type="equal">
<label>$</label>
<p id="P1">contributed equally and would like to be known as joint first authors.</p>
</fn>
<corresp id="CR1">
<label>#</label>address for correspondence :</corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>11</day>
<month>09</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="preprint">
<day>09</day>
<month>09</month>
<year>2020</year>
</pub-date>
<permissions>
<license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">
<license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">CC BY-NC 4.0 International license</ext-link>.</license-p>
</license>
</permissions>
<abstract>
<p id="P2">Coronavirus disease 2019 (COVID-19) rapidly spread from a city in China to almost every country in the world, affecting millions of individuals. Genomic approaches have been extensively used to understand the evolution and epidemiology of SARS-CoV-2 across the world. Kerala is a unique state in India well connected with the rest of the world through a large number of expatriates, trade, and tourism. The first case of COVID-19 in India was reported in Kerala in January 2020, during the initial days of the pandemic. The rapid increase in the COVID-19 cases in the state of Kerala has necessitated the understanding of the genetic epidemiology of circulating virus, evolution, and mutations in SARS-CoV-2. We sequenced a total of 200 samples from patients at a tertiary hospital in Kerala using COVIDSeq protocol at a mean coverage of 7,755X. The analysis identified 166 unique high-quality variants encompassing 4 novel variants and 89 new variants identified for the first time in SARS-CoV-2 samples isolated from India. Phylogenetic and haplotype analysis revealed that the circulating population of the virus was dominated (94.6% of genomes) by three distinct introductions followed by local spread, apart from identifying polytomies suggesting recent outbreaks. The genomes formed a monophyletic distribution exclusively mapping to the A2a clade. Further analysis of the functional variants revealed two variants in the <italic>S</italic> gene of the virus reportedly associated with increased infectivity and 5 variants that mapped to five primer/probe binding sites that could potentially compromise the efficacy of RT-PCR detection. To the best of our knowledge, this is the first and most comprehensive report of genetic epidemiology and evolution of SARS-CoV-2 isolates from Kerala.</p>
</abstract>
<kwd-group>
<kwd>COVID19</kwd>
<kwd>COVIDSeq</kwd>
<kwd>Kerala</kwd>
<kwd>Genetic epidemiology</kwd>
<kwd>Variants</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="S1" sec-type="intro">
<title>Introduction</title>
<p id="P3">The COVID-19 pandemic has seen a widespread application of genomic approaches to understand the epidemiology and evolution of SARS-CoV-2. The accelerated efforts to sequence genomes of clinical isolates of SARS-CoV-2 from across the world picked up pace following the initial genome sequencing of the virus from a patient in Wuhan, the epicenter for the pandemic [<xref ref-type="bibr" rid="R1">1</xref>]). As the virus evolves through the accumulation of mutations, it has split into major lineages with strong geographical affinities [<xref ref-type="bibr" rid="R2">2</xref>]. The availability of the genome sequences in the public domain has provided a unique view of the introduction, evolution, and dynamics of SARS-CoV-2 in different parts of the world [<xref ref-type="bibr" rid="R3">3</xref>].</p>
<p id="P4">A number of approaches have emerged for rapid and scalable sequencing of SARS-CoV-2 from clinical isolates. This includes direct shotgun approaches as well as targeted amplicon-based and targeted capture-based approaches [<xref ref-type="bibr" rid="R4">4</xref>–<xref ref-type="bibr" rid="R6">6</xref>]. Sequencing based approaches provide a unique opportunity for high fidelity of detection and for understanding the genetic epidemiology of SARS-CoV-2 [<xref ref-type="bibr" rid="R7">7</xref>]. Additionally, the genetic variants could offer insights into the mutational spectrum, evolution, infectivity, and attenuation of the virus [<xref ref-type="bibr" rid="R8">8</xref>,<xref ref-type="bibr" rid="R9">9</xref>]. Additional analyses on genomic variants have also provided useful insights into the efficacy of primer/probe-based diagnostic assays as well as immune epitopes and resistance to antisera [<xref ref-type="bibr" rid="R10">10</xref>,<xref ref-type="bibr" rid="R11">11</xref>]. An approach for high-throughput multiplex amplicon sequencing of SARS-CoV-2 has been previously reported from our group [<xref ref-type="bibr" rid="R7">7</xref>].</p>
<p id="P5">Kerala is a unique state in India with a population of 35 million people and extensively connected with the global populations through over 1.6 million expatriates, apart from being a traditional trade post and a global tourist destination. The state is therefore in a distinct position, affected by local as well as global epidemics. In fact, the first identified case of COVID-19 in India was from Kerala, early in the epidemic. The patient had traveled from Wuhan, China [<xref ref-type="bibr" rid="R12">12</xref>,<xref ref-type="bibr" rid="R13">13</xref>]. The initial genomic identity of the virus was also established which mapped to the B superclade of SARS-CoV-2 [<xref ref-type="bibr" rid="R14">14</xref>]. Further introductions into the state during the later days of the pandemic through international and regional travel could have contributed to the spread of the epidemic in the state and the pool of circulating genetic lineages or clades. While a number of studies on the genetic epidemiology of SARS-CoV-2 from different states in India have emerged [<xref ref-type="bibr" rid="R14">14</xref>–<xref ref-type="bibr" rid="R17">17</xref>], there has been a paucity of information on the genetic architecture and epidemiology of SARS-CoV-2 isolates in the state of Kerala.</p>
<p id="P6">We intended to fulfill the gap in knowledge on the identity of the circulating genetic lineages/clades contributing to the epidemic in the state of Kerala. To this end, we employed a high-throughput sequencing-based approach for the genetic epidemiology of SARS-CoV-2. To the best of our knowledge, this is the first comprehensive overview of the genetic architecture of SARS-CoV-2 isolates from the state of Kerala.</p>
</sec>
<sec id="S2" sec-type="materials | methods">
<title>Materials and Methods</title>
<sec id="S3">
<title>Samples and RNA isolation</title>
<p id="P7">The institutional Human Ethics Committee approved the project (GMC KKD/RP2020/IEC438). RNA samples were isolated from nasopharyngeal/oropharyngeal swabs of patients presenting to Government Medical College, Kozhikode, a major tertiary care center in Kerala. RNA extraction was done using MagMax Viral/Pathogen Nucleic Acid Isolation kit in Thermo Scientific KingFisher Flex automated extraction system according to the manufacturer's instructions. All the RNA samples were transferred within 72 hours of collection at a cold temperature (2-8°C) and were stored at -80°C until further processing.</p>
</sec>
<sec id="S4">
<title>Sequencing and Data Processing</title>
<p id="P8">Sequencing was performed using the COVIDSeq protocol as reported previously [<xref ref-type="bibr" rid="R7">7</xref>]. Briefly, this protocol involved multiplex amplicon sequencing on the Illumina NovaSeq platform. The base calls generated in the binary base call (BCL) format were demultiplexed to FASTQ reads using bcl2fastq (v2.20). For reference-based assembly, we followed a previously defined protocol from Poojary et al. [<xref ref-type="bibr" rid="R18">18</xref>]. As per the protocol, the quality control of FASTQ reads was performed using Trimmomatic (v0.39) at a Phred score of Q30 [<xref ref-type="bibr" rid="R19">19</xref>] with adapter trimming. These reads were further aligned to the severe acute respiratory syndrome 2 (SARS-CoV-2) Wuhan-Hu-1 reference genome (NC_045512.2) using HISAT2-2.1 [<xref ref-type="bibr" rid="R20">20</xref>]. The human reads were removed using SaMtools (v1.10) [<xref ref-type="bibr" rid="R21">21</xref>]. The samples with coverage &gt;99% and &lt;5% unassigned nucleotides underwent variant calling and consensus sequences generation using VarScan (v2.4.4) [<xref ref-type="bibr" rid="R22">22</xref>] and SaMtools (v1.10) [<xref ref-type="bibr" rid="R21">21</xref>], bcftools (v1.10.2), and seqtk (v 1.3-r114) [<xref ref-type="bibr" rid="R23">23</xref>] respectively.</p>
</sec>
<sec id="S5">
<title>Variant Annotation and Comparison with Existing Datasets</title>
<p id="P9">Variants were annotated using ANNOVAR [<xref ref-type="bibr" rid="R24">24</xref>] employing a range of custom annotation datasets and tables. All the variants identified were systematically compared with a compendium of other Indian and global variants. A total of 93,995 complete SARS-CoV-2 genomes deposited in the Global Initiative on Sharing All Influenza Data (GISAID) database till September 1, 2020 were used for comparative analysis. Summary of the sample details along with their originating and submitting laboratories are provided in <xref ref-type="supplementary-material" rid="SD1">Supplementary Table 1</xref>. Viral genomes with a pairwise alignment ≥ 99% and gaps &lt; 1% with the reference genome (NC_045512.2) were considered for further variant calling using SNP-sites [<xref ref-type="bibr" rid="R25">25</xref>]. Genetic variants compiled from a total of 1,855 high-quality genomes from India and 32,286 global genomes were considered for analysis.</p>
</sec>
<sec id="S6">
<title>Phylogenetic Analysis</title>
<p id="P10">Phylogenetic analysis was performed according to the pipeline provided by Nextstrain [<xref ref-type="bibr" rid="R26">26</xref>]. The dataset of 2,476 complete SARS-CoV-2 genomes deposited in the GISAID database from India was used for the analysis <xref ref-type="supplementary-material" rid="SD3">Supplementary Table 2</xref>, along with 113 genomes from the current study which have 99% coverage and at least 98% pairwise alignment with the reference genome (NC_045512.2). Genomes having more than 5% Ns or missing dates of sample collection were excluded from the analysis. The phylogenetic tree was constructed and refined to a molecular clock phylogeny using the Augur framework provided by Nextstrain and was visualized using Auspice. The Phylogenetic Assignment of Named Global Outbreak LINeages (PANGOLIN) package was used to assign lineages to the genomes from this study [<xref ref-type="bibr" rid="R27">27</xref>]. The lineages were visualized and annotated on the phylogenetic tree using iToL [<xref ref-type="bibr" rid="R28">28</xref>].</p>
</sec>
<sec id="S7">
<title>Haplotype Analysis</title>
<p id="P11">For haplotype analysis, the genomes were aligned to the Wuhan-Hu-1 (NC_045512.2) reference genome using MAFFT [<xref ref-type="bibr" rid="R29">29</xref>] and problematic genomic loci (low coverage, high sequencing error rate, hypermutable and homoplasic sites) were masked from the alignment [<xref ref-type="bibr" rid="R30">30</xref>]. The aligned sequences were imported into the DNA Sequence Polymorphism tool (DnaSP v6.12.03) [<xref ref-type="bibr" rid="R31">31</xref>] to generate haplotypes. A TCS haplotype network [<xref ref-type="bibr" rid="R32">32</xref>] for the genomes was constructed using the Population Analysis with Reticulate Trees software (POPART v 1.7) [<xref ref-type="bibr" rid="R33">33</xref>]. Times to the most recent common ancestor (tMRCA) for the haplogroups were computed following the Bayesian Markov chain Monte Carlo (MCMC) method using BEAST v1.10.4 [<xref ref-type="bibr" rid="R34">34</xref>]. The analysis was performed using a coalescent growth rate model along with a strict molecular clock and the HKY+Γ substitution model with gamma-distributed rate variation (gamma categories=4). MCMC was run for 50 million steps. The output was analyzed in Tracer v1.7.1 [<xref ref-type="bibr" rid="R35">35</xref>] and burn-in was adjusted to attain an appropriate effective sample size (ESS).</p>
</sec>
<sec id="S8">
<title>Functional SARS-CoV-2 variants</title>
<p id="P12">Further, we have evaluated the SARS-CoV-2 variants based on their functional relevance. We curated a comprehensive compendium of SARS-CoV-2 variants of functional relevance as well as variants that are associated with increased infectivity and attenuation of SARS-CoV-2 from literature and preprint servers. The variants were systematically annotated and mapped to the reference genome coordinates and their respective amino acid changes. This variant compendium encompassed about 337 variants curated from 35 publications. The variants in this study were compared with the genomic variants generated using bespoke scripts.</p>
</sec>
<sec id="S9">
<title>Variant effect on RT-PCR efficacy</title>
<p id="P13">We were also interested to evaluate the effect of SARS-CoV-2 variants on the efficacy of RT-PCR detection. We took a compiled list of 132 primer/probe sequences widely used in the molecular detection of SARS-CoV-2 around the globe [<xref ref-type="bibr" rid="R11">11</xref>]. In our analysis, we mapped the SARS-CoV-2 genetic variants obtained from Kerala genomes to the 132 primer or probes sequence and calculated the melting temperature (Tm) of the mutant with the wild type sequence. The length of primers in the curated list is greater than 13 nucleotides. The formula applied for calculating melting temperature is Tm=64.9 +41*(yG+zC-16.4)/(wA+xT+yG+zC) where w, x, y, and z are the number of A, T, G, and C nucleotides respectively [<xref ref-type="bibr" rid="R36">36</xref>]. <xref ref-type="fig" rid="F1">Figure 1</xref> summarises the schematic for the overall data analysis.</p>
</sec>
</sec>
<sec id="S10" sec-type="results">
<title>Results</title>
<sec id="S11">
<title>Sequencing and Data Processing</title>
<p id="P14">A total of 200 isolates of SARS-CoV-2 from Kerala were processed for genome sequencing. The genomes were sequenced using COVIDSeq protocol [<xref ref-type="bibr" rid="R7">7</xref>] and generated approximately 8.1 million raw reads per sample. The reads were subjected to quality control and resulted in approximately 7.5 million reads per sample, of which around 6.4 million reads per sample aligned to the SARS-CoV-2 reference genome (NC_045512.2). The reads had a mapping percentage of 84.93% and mean 7,755X coverage. The data has been summarized in <xref ref-type="supplementary-material" rid="SD2">Supplementary Table 3</xref> and the mean coverage of the sample across the amplicons has been represented in <xref ref-type="fig" rid="F2">Figure 2</xref>.</p>
</sec>
<sec id="S12">
<title>Variant Annotation and Comparison with Existing Datasets</title>
<p id="P15">Of the 200 isolates of SARS-CoV-2 sequenced, a total of 179 samples had &gt; 99% coverage and &lt;5% unassigned nucleotides across the genome. These samples were further processed for variant calling and consensus generation. Our analysis identified a total of 195 unique variants, with a median variant count of 12 per sample. Variant quality has been ensured with the average variation percentage across genomes ≥ 50. Of the total 195 unique variants, 166 were categorized as high-quality variants. The detailed information on variant quality is provided in <xref ref-type="supplementary-material" rid="SD10">Supplementary Table 4</xref>. The distribution of variants across the SARS-CoV-2 genomes used in the study was analyzed. Also, the proportional distribution of variants for every 100 bps across the genome was calculated and compared among various datasets. Variant distribution across genomes and comparison of variant proportions across genome datasets are represented in <xref ref-type="fig" rid="F3">Figure 3</xref>. Out of the 166 high-quality unique variants, 4 variants were found to be reported for the first time in the global compilation of variants <xref ref-type="table" rid="T1">Table 1</xref>. We have also added 89 new variants (2.61%) to the Indian repertoire of genetic variants. Details of these variants are systematically compiled in <xref ref-type="supplementary-material" rid="SD6">Supplementary Table 5</xref>. The overlap in the variants between the present study of Kerala, other Indian, and global datasets is summarized in <xref ref-type="supplementary-material" rid="SD7">Supplementary Figure 1</xref>. Out of the 4 novel variants, 1 variant in the S gene, 25281G&gt;A, was a personal variant and was not shared by any other isolate. The remaining three novel variants were shared variants and were present in different genes (Orf1b, Orf7a and S).</p>
</sec>
<sec id="S13">
<title>Genomic context and classification of the variants</title>
<p id="P16">Of the total 166 high-quality unique variants, 162 variants were located in the protein-coding regions while 4 variants mapped to either downstream or upstream regions. Of the total variants in protein-coding regions, 93 variants were non-synonymous, 67 were synonymous, and 2 variants resulted in stopgain mutation. These two stopgain variants were found in ORF3a (26113:G&gt;T) and ORF8 (28028:G&gt;A) genes and were present in one individual each. The annotation of the variants based on the location and consequence is represented in <xref ref-type="fig" rid="F3">Figure 3</xref>.</p>
</sec>
<sec id="S14">
<title>Phylogenetic analysis</title>
<p id="P17">The phylogenetic tree was constructed using the genome Wuhan/WH01 (EPI_ISL_406798) as root and 2366 genomes from India which met the inclusion criteria (Ns &lt; 5%, no missing/ambiguous date of sample collection) including 113 genomes sequenced in this study. All 113 genomes from this study were found to cluster under the globally predominant clade A2a (GISAID clade G and GH). In contrast, one of the previous genomes available from Kerala (EPI_ISL_413523, submitted by National Institute of Virology, Pune, India), which is also one of the first SARS-CoV-2 genomes sequenced in India, belongs to the clade B [<xref ref-type="bibr" rid="R13">13</xref>].</p>
<p id="P18">The dominant lineage assigned by PANGOLIN for the 113 genomes was found to be B.1 (n=110), while 3 genomes were assigned the lineage B.1.113. The phylogenetic map of the dataset of Indian genomes and the distribution of lineages in the 113 genomes from Kerala are summarized in <xref ref-type="fig" rid="F4">Figure 4</xref>.</p>
</sec>
<sec id="S15">
<title>Haplotype Analysis</title>
<p id="P19">Haplotype analysis was done using a dataset of 850 SARS-CoV-2 genomes from India (including 113 genomes from Kerala) that fell under clade A2a in the phylogenetic tree and clustered close to the 113 genomes from Kerala. Among the 850 genomes, there were 592 variable sites and 400 unique haplotypes <xref ref-type="supplementary-material" rid="SD4">Supplementary Table 6</xref>. The haplotype network as generated by POPART shows that a few haplogroups contributed to a majority of the isolates. Three major haplogroups contributed to 94.6% of the isolates from Kerala. The major haplogroup (K1) encompassed 40 genomes from Kerala (35.4%). The network suggests that the cluster K1 had a potential ancestor from the state of Maharashtra before possible introduction and dissemination in Kerala. A variant 16726C&gt;T was observed to be common between the 40 genomes as well as the 3 genomes from Maharashtra belonging to the ancestral haplotype. The K1 cluster also included 4 genomes from Kerala which were found to be in a polytomy in the phylogenetic tree. Close follow-up of the cases suggests a local outbreak which contributed to the polytomy. The second haplogroup (K2) encompasses 42 genomes (37.1%) from Kerala and shares 27 genomes from Odisha. In addition, 5 genomes from Kerala in this group also constitute a polytomy. The third group (K3) encompasses 25 genomes (22.1%) from Kerala and shares 46 genomes from Karnataka. <xref ref-type="fig" rid="F5">Figure 5</xref> summarizes the haplotype network of the A2a clade genomes.</p>
<p id="P20">To understand the times of introduction, tMRCA was computed for the 3 distinct haplogroups. The median tMRCA were 14 July 2020 (95% highest posterior density interval [HPD] 11 May - 22 July), 20 March 2020 (95% HPD 12 Feb - 16 May), and 6 April 2020 (95% HPD 3 March - 27 May) for the three major haplogroups K1, K2, and K3 respectively. Taken together, the analysis suggests that the majority of the SARS-COV-2 isolates are outcomes of limited introductions early in the epidemic followed by local circulation.</p>
</sec>
<sec id="S16">
<title>Functional consequences of the variants</title>
<p id="P21">Annotating the variants for their functional consequences using custom annotation datasets, revealed a total of 42 genetic variants that were predicted as deleterious by SIFT [<xref ref-type="bibr" rid="R37">37</xref>]. The filtered variants were found to span 13 unique protein domains as per UNIPROT [<xref ref-type="bibr" rid="R38">38</xref>] annotations. We found 15 and 120 genetic variants that mapped back to potential B and T cell epitopes from the Immune Epitope Database (IEDB) [<xref ref-type="bibr" rid="R39">39</xref>] respectively. In addition, 5 variants were found to span predicted error-prone sites including sequencing error sites, homoplasic positions, and hypermutable sites. Functional annotation details of all the filtered variants are summarised in <xref ref-type="supplementary-material" rid="SD5">Supplementary Table 7</xref>.</p>
</sec>
<sec id="S17">
<title>Variants in diagnostic primer/probe binding sites in the genome</title>
<p id="P22">We also explored whether the variants mapped to the RT-PCR primers and probes sites. On mapping the genetic variants with the curated primers and probes, we found 5 unique variants at 5 unique primer or probes binding sites. A total of four unique variants had allele frequency &gt; 1% at 4 unique primer binding sites. The majority of the variants i.e. 4 lies in the primer binding sites in <italic>ORF1b, S, E</italic>, and <italic>N</italic> with an allele frequency of 0.559%, 4.469%, 1.117%, and 3.352% in the Kerala isolate genomes respectively. While a variant 28899:G&gt;T mapped to the 2019-nCoV-NFP, which is a part of China Centers for Disease Control and Prevention (CDC) primer set with a frequency of 1.117%, the Tm differed in the mutated sequence by the unit of ± 2 in comparison to the wild type sequence.</p>
<p id="P23">Summary of novel variants and diagnostic primer/probe spanning variants are compiled in <xref ref-type="table" rid="T1">Table 1</xref> and <xref ref-type="table" rid="T2">Table 2</xref> respectively. Details on the read count and depth of coverage of these variants are systematically documented in <xref ref-type="supplementary-material" rid="SD8">Supplementary Table 8.a</xref> and <xref ref-type="supplementary-material" rid="SD9">8.b</xref>.</p>
</sec>
<sec id="S18">
<title>Variants associated with potential increased infectivity or attenuation of the virus in experimental settings</title>
<p id="P24">With the view of identifying potential functionally relevant variants, we overlapped the variants obtained from the present study with a manually curated compilation of functionally relevant SARS-CoV-2 variants. Our analysis identified 2 variants in the S gene which were reported to be associated with increased infectivity. L5F, a variation co-occurring with D614G was earlier demonstrated to possess increased infectivity [<xref ref-type="bibr" rid="R8">8</xref>,<xref ref-type="bibr" rid="R40">40</xref>] using cell line studies. In our study, 23403A&gt;G (D614G) and 21575C&gt;T (L5F) mutations were observed at frequencies of 99.44% and 15.64% respectively in the genomes. The combination of these variations was found to occur at a higher frequency in genomes from Kerala.</p>
</sec>
</sec>
<sec id="S19" sec-type="discussion | conclusions">
<title>Discussion and Conclusions</title>
<p id="P25">Within a small time frame, SARS-CoV-2 has spread from Wuhan (Hubei province, China) to countries across the world affecting over 26 million individuals [<ext-link ext-link-type="uri" xlink:href="https://covid19.who.int/">https://covid19.who.int/</ext-link>]. The virus evolves by accumulating variants at an almost constant rate of 1.19 to 1.31 × 10-3 base substitutions per site per year [<xref ref-type="bibr" rid="R2">2</xref>] and therefore leaves the mutational fingerprint which is widely used for tracing the spread of the virus [<xref ref-type="bibr" rid="R41">41</xref>]. The availability of high-throughput sequencing approaches has enabled researchers to sequence genomes as the pandemic progressed in their respective countries. A number of methods have been adopted for rapid high throughput sequencing of SARS-CoV-2 including shotgun sequencing [<xref ref-type="bibr" rid="R4">4</xref>], PCR amplicon, and hybridization/capture-based enrichment and sequencing [<xref ref-type="bibr" rid="R5">5</xref>–<xref ref-type="bibr" rid="R7">7</xref>].</p>
<p id="P26">Genome sequencing of SARS-CoV-2 in various countries[<xref ref-type="bibr" rid="R42">42</xref>] has led to to insights into the temporal and geographical spread of the virus [<xref ref-type="bibr" rid="R43">43</xref>], introductions, and spread of the virus through travelers [<xref ref-type="bibr" rid="R44">44</xref>,<xref ref-type="bibr" rid="R45">45</xref>], local transmission, and dynamics [<xref ref-type="bibr" rid="R46">46</xref>], investigating the origin of outbreaks [<xref ref-type="bibr" rid="R47">47</xref>], just to name a few. By virtue of its connectivity to major cities through its expatriate population, trade and tourism is uniquely poised in this pandemic. It is not surprising therefore that the first case of COVID-19 in India, early in the pandemic, was reported from the state [<xref ref-type="bibr" rid="R12">12</xref>,<xref ref-type="bibr" rid="R13">13</xref>]. The genome of the isolate suggested it originated from China [<xref ref-type="bibr" rid="R13">13</xref>]. The following months have seen the number of cases increase to over 80 thousand in the state with a paucity of information on the origin, spread, and dynamics of the virus [<ext-link ext-link-type="uri" xlink:href="https://dashboard.kerala.gov.in/">https://dashboard.kerala.gov.in/</ext-link>].</p>
<p id="P27">In this present study, we performed sequencing and analysis of SARS-CoV-2 isolates from Kerala which revealed unique patterns of the transmission. These genomes are clustered into a monophyletic group mapping to the A2a clade. The A2a clade is also marked by the D614G variant, which is suggested to confer higher infectivity to the virus in experimental in vitro settings [<xref ref-type="bibr" rid="R48">48</xref>,<xref ref-type="bibr" rid="R49">49</xref>] and is therefore thought to have emerged globally as the predominant clade [<xref ref-type="bibr" rid="R8">8</xref>], though the cause-effect relationship still remains speculative. Haplotype analysis suggests that three major haplogroups with distinct ancestry groups encompass the majority of the isolates. The haplotype analysis in the context of other genomes from India suggests the introductions were from inter-state travel. The prevalent haplotypes were not found in any of the global genomes, supporting this observation. This also suggests that focussed testing, tracing and quarantine of expatriates and international travelers implemented during the epidemic would have been effective in curbing the spread from international travelers. The genome clusters also suggested polytomies, suggesting a recent outbreak [<xref ref-type="bibr" rid="R17">17</xref>]. Close follow-up of the cluster members confirmed the potential source of the outbreak, suggesting genetic epidemiology could be used in conjunction with case follow-ups to uncover potential outbreaks and possibly connect outbreaks which are apparently not related.</p>
<p id="P28">This study uncovered a total of 4 novel genetic variants and 89 variants which were identified only in Kerala and not in the rest of India. The genome sequences could also uncover insights into the variants of functional relevance. One of the variants of significance is a stopgain variant (28028:G&gt;A) in the ORF8 gene. Variants including deletions in ORF8 have been suggested to attenuate the virus [<xref ref-type="bibr" rid="R50">50</xref>,<xref ref-type="bibr" rid="R51">51</xref>]. Similar variants have also been identified in other related viruses like the SARS-CoV and MERS-CoV [<xref ref-type="bibr" rid="R9">9</xref>,<xref ref-type="bibr" rid="R52">52</xref>]. A variant 21575C&gt;T (L5F) in the <italic>S</italic> gene associated with increased infectivity of the virus [<xref ref-type="bibr" rid="R40">40</xref>] was present in 15.64% of the genomes sequenced. Following recent reports which suggest variants in the primer/probe binding sites could impact the efficiency of RT-PCR assays [<xref ref-type="bibr" rid="R11">11</xref>,<xref ref-type="bibr" rid="R53">53</xref>,<xref ref-type="bibr" rid="R54">54</xref>], we explored whether any of the variants in the present study mapped to the primer/probe binding sites. We identified 5 unique variants in 5 unique binding sites. The maximum number of variants were the primer set published by Won et al. [<xref ref-type="bibr" rid="R55">55</xref>] spanning multiple genes, apart from the 2019-nCoV-NFP GGGGAACTTCTCCTGCTAGAAT binding sites in the N gene [<ext-link ext-link-type="uri" xlink:href="https://www.who.int/docs/default-source/coronaviruse/whoinhouseassays.pdf?sfvrsn=de3a76aa_2">https://www.who.int/docs/default-source/coronaviruse/whoinhouseassays.pdf?sfvrsn=de3a76aa_2</ext-link>]. The latter is part of the China Centers for Disease Control and Prevention (CDC) protocol with variants in 1.117% in genomes from Kerala. We have earlier reported variants in this primer site in 39.5% of the genomes from India [<xref ref-type="bibr" rid="R11">11</xref>] and 18.8% [<xref ref-type="bibr" rid="R56">56</xref>] of global genomes. This information would be potentially valuable for laboratories in selecting reagents for screening and diagnosis.</p>
<p id="P29">The study has two caveats; first is that the samples were collected from a single major tertiary care center in North Kerala. However, the center caters to a large population and region and has close proximity to an international airport. Secondly, the sampling was limited to a short period of time, thus enabling only a cross-sectional view of the epidemic and precluding an accurate and temporal view of the dynamics of the epidemic in the state. Nevertheless, this provides a unique opportunity to create a snapshot of the epidemic in time and space. Notwithstanding the limitations, this is the first and most comprehensive overview of the genetic epidemiology of SARS-CoV-2 in the state of Kerala. While providing insights into the epidemiology of the epidemic, the study also enabled tracing outbreaks thereby highlighting the utility of genome sequencing as an adjunct to high-throughput screening and testing. It has not escaped our mind that scalable technologies that can combine both the approaches [<xref ref-type="bibr" rid="R7">7</xref>] could potentially find a place in understanding epidemics better.</p>
</sec>
<sec sec-type="supplementary-material" id="SM">
<title>Supplementary Material</title>
<supplementary-material content-type="local-data" id="SD1">
<label>Supplementary Table 1</label>
<caption>
<title>GISAID acknowledgment table for global genomes used in the study</title>
</caption>
<media xlink:href="EMS94924-supplement-Supplementary_Table_1.pdf" mimetype="application" mime-subtype="pdf" id="N66665" position="anchor"/>
</supplementary-material>
<supplementary-material content-type="local-data" id="SD2">
<label>Supplementary Table 3</label>
<caption>
<title>Data summary of the samples sequenced by COVIDSeq Protocol and processed using a custom pipeline.</title>
</caption>
<media xlink:href="EMS94924-supplement-Supplementary_Table_3.pdf" mimetype="application" mime-subtype="pdf" id="N66677" position="anchor"/>
</supplementary-material>
<supplementary-material content-type="local-data" id="SD3">
<label>Supplementary Table 2</label>
<caption>
<title>GISAID acknowledgment table for genomes from India considered for phylogenetic analysis</title>
</caption>
<media xlink:href="EMS94924-supplement-Supplementary_Table_2.pdf" mimetype="application" mime-subtype="pdf" id="N66689" position="anchor"/>
</supplementary-material>
<supplementary-material content-type="local-data" id="SD4">
<label>Supplementary Table 6</label>
<caption>
<title>Unique haplotypes for the dataset of 850 genomes belonging to clade A2a.</title>
</caption>
<media xlink:href="EMS94924-supplement-Supplementary_Table_6.pdf" mimetype="application" mime-subtype="pdf" id="N66701" position="anchor"/>
</supplementary-material>
<supplementary-material content-type="local-data" id="SD5">
<label>Supplementary Table 7</label>
<caption>
<title>Summary of functional annotation of unique genetic variants identified in the study.</title>
</caption>
<media xlink:href="EMS94924-supplement-Supplementary_Table_7.pdf" mimetype="application" mime-subtype="pdf" id="N66713" position="anchor"/>
</supplementary-material>
<supplementary-material content-type="local-data" id="SD6">
<label>Supplementary Table 5</label>
<caption>
<title>Compilation of genetic variants identified for the first time in Indian genomes.</title>
</caption>
<media xlink:href="EMS94924-supplement-Supplementary_Table_5.pdf" mimetype="application" mime-subtype="pdf" id="N66725" position="anchor"/>
</supplementary-material>
<supplementary-material content-type="local-data" id="SD7">
<label>Supplementary Figure 1</label>
<media xlink:href="EMS94924-supplement-Supplementary_Figure_1.pdf" mimetype="application" mime-subtype="pdf" id="N66734" position="anchor"/>
</supplementary-material>
<supplementary-material content-type="local-data" id="SD8">
<label>Supplementary Table 8a</label>
<caption>
<title>Tabulation of read alignment statistics for variants spanning Primer/Probe sites</title>
</caption>
<media xlink:href="EMS94924-supplement-Supplementary_Table_8a.pdf" mimetype="application" mime-subtype="pdf" id="N66746" position="anchor"/>
</supplementary-material>
<supplementary-material content-type="local-data" id="SD9">
<label>Supplementary Table 8b</label>
<caption>
<title>Tabulation of read alignment statistics for Novel variants</title>
</caption>
<media xlink:href="EMS94924-supplement-Supplementary_Table_8b.pdf" mimetype="application" mime-subtype="pdf" id="N66758" position="anchor"/>
</supplementary-material>
<supplementary-material content-type="local-data" id="SD10">
<label>Supplementary Table 4</label>
<caption>
<title>Summary of quality details of the variants identified in the study</title>
</caption>
<media xlink:href="EMS94924-supplement-Supplementary_Table_4.pdf" mimetype="application" mime-subtype="pdf" id="N66770" position="anchor"/>
</supplementary-material>
</sec>
</body>
<back>
<ack id="S20">
<title>Acknowledgements</title>
<p>Authors thank Anjali Bajaj for editorial assistance. AJ, MD, BJ acknowledge research fellowships from CSIR. DS acknowledges a research fellowship from Intel. Authors acknowledge funding for the work from the Council of Scientific and Industrial Research (CSIR), India through grants CODEST and MLP2005. The funders had no role in the design of experiment, analysis, or decision to publish.</p>
</ack>
<ref-list>
<ref id="R1">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>B</given-names>
</name>
<etal/>
</person-group>
<article-title>A new coronavirus associated with human respiratory disease in China</article-title>
<source>Nature</source>
<year>2020</year>
<volume>579</volume>
<issue>7798</issue>
<fpage>265</fpage>
<lpage>269</lpage>
</element-citation>
</ref>
<ref id="R2">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Zai</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Q</given-names>
</name>
<etal/>
</person-group>
<article-title>Evolutionary history, potential intermediate animal host, and cross-species analyses of SARS-CoV-2</article-title>
<source>J Med Virol</source>
<year>2020</year>
<volume>92</volume>
<issue>6</issue>
<fpage>602</fpage>
<lpage>611</lpage>
</element-citation>
</ref>
<ref id="R3">
<label>3</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>McCauley</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>GISAID: Global initiative on sharing all influenza data - from vision to reality</article-title>
<source>Euro Surveill</source>
<year>2017</year>
<volume>22</volume>
<issue>13</issue>
</element-citation>
</ref>
<ref id="R4">
<label>4</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meredith</surname>
<given-names>LW</given-names>
</name>
<name>
<surname>Hamilton</surname>
<given-names>WL</given-names>
</name>
<name>
<surname>Warne</surname>
<given-names>B</given-names>
</name>
<etal/>
</person-group>
<article-title>Rapid implementation of SARS-CoV-2 sequencing to investigate cases of health-care associated COVID-19: a prospective genomic surveillance study</article-title>
<source>Lancet Infect Dis</source>
<year>2020</year>
</element-citation>
</ref>
<ref id="R5">
<label>5</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xiao</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Ji</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group>
<article-title>Multiple approaches for massively parallel sequencing of SARS-CoV-2 genomes directly from clinical samples</article-title>
<source>Genome Med</source>
<year>2020</year>
<volume>12</volume>
<issue>1</issue>
<fpage>57</fpage>
</element-citation>
</ref>
<ref id="R6">
<label>6</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yángüez</surname>
<given-names>E</given-names>
</name>
<name>
<surname>White</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Kreutzer</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group>
<article-title>HiDRA-seq: High-Throughput SARS-CoV-2 Detection by RNA Barcoding and Amplicon Sequencing</article-title>
<source>bioRxiv</source>
<year>2020</year>
<comment>2020.06.02.130484</comment>
</element-citation>
</ref>
<ref id="R7">
<label>7</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bhoyar</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Jain</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sehgal</surname>
<given-names>P</given-names>
</name>
<etal/>
</person-group>
<article-title>High throughput detection and genetic epidemiology of SARS-CoV-2 using COVIDSeq next generation sequencing</article-title>
<source>bioRxiv</source>
<year>2020</year>
<comment>2020.08.10.242677</comment>
</element-citation>
</ref>
<ref id="R8">
<label>8</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Korber</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Fischer</surname>
<given-names>WM</given-names>
</name>
<name>
<surname>Gnanakaran</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group>
<article-title>Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus</article-title>
<source>Cell</source>
<year>2020</year>
<volume>182</volume>
<issue>4</issue>
<fpage>812</fpage>
<lpage>827.e19</lpage>
</element-citation>
</ref>
<ref id="R9">
<label>9</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Muth</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Corman</surname>
<given-names>VM</given-names>
</name>
<name>
<surname>Roth</surname>
<given-names>H</given-names>
</name>
<etal/>
</person-group>
<article-title>Attenuation of replication by a 29 nucleotide deletion in SARS-coronavirus acquired during the early stages of human-to-human transmission</article-title>
<source>Sci Rep</source>
<year>2018</year>
<volume>8</volume>
<issue>1</issue>
<comment>15177</comment>
</element-citation>
</ref>
<ref id="R10">
<label>10</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grifoni</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sidney</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Scheuermann</surname>
<given-names>RH</given-names>
</name>
<name>
<surname>Peters</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Sette</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>A Sequence Homology and Bioinformatic Approach Can Predict Candidate Targets for Immune Responses to SARS-CoV-2</article-title>
<source>Cell Host Microbe</source>
<year>2020</year>
<volume>27</volume>
<issue>4</issue>
<fpage>671</fpage>
<lpage>680.e2</lpage>
</element-citation>
</ref>
<ref id="R11">
<label>11</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jain</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Rophina</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mahajan</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group>
<article-title>Analysis of the potential impact of genomic variants in SARS-CoV-2 genomes from India on molecular diagnostic assays</article-title>
<source>bioRxiv</source>
<year>2020</year>
<comment>2020.08.05.238618</comment>
</element-citation>
</ref>
<ref id="R12">
<label>12</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sarkale</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Patil</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Yadav</surname>
<given-names>PD</given-names>
</name>
<etal/>
</person-group>
<article-title>First isolation of SARS-CoV-2 from clinical samples in India</article-title>
<source>Indian J Med Res</source>
<year>2020</year>
<volume>151</volume>
<issue>2 &amp; 3</issue>
<fpage>244</fpage>
<lpage>250</lpage>
</element-citation>
</ref>
<ref id="R13">
<label>13</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yadav</surname>
<given-names>PD</given-names>
</name>
<name>
<surname>Potdar</surname>
<given-names>VA</given-names>
</name>
<name>
<surname>Choudhary</surname>
<given-names>ML</given-names>
</name>
<etal/>
</person-group>
<article-title>Full-genome sequences of the first two SARS-CoV-2 viruses from India</article-title>
<source>Indian J Med Res</source>
<year>2020</year>
<volume>151</volume>
<issue>2 &amp; 3</issue>
<fpage>200</fpage>
<lpage>209</lpage>
</element-citation>
</ref>
<ref id="R14">
<label>14</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Somasundaram</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Mondal</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lawarde</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Genomics of Indian SARS-CoV-2: Implications in genetic diversity, possible origin and spread of virus</article-title>
<source>medRxiv</source>
<publisher-name>Cold Spring Harbor Laboratory Press</publisher-name>
<year>2020</year>
<comment>2020.04.25.20079475</comment>
</element-citation>
</ref>
<ref id="R15">
<label>15</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saha</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Ghosh</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Maity</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Sharma</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Sarkar</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Mitra</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Genome-wide analysis of Indian SARS-CoV-2 genomes for the identification of genetic mutation and SNP</article-title>
<source>Infect Genet Evol</source>
<year>2020</year>
<volume>85</volume>
<comment>104457</comment>
</element-citation>
</ref>
<ref id="R16">
<label>16</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Paul</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Jani</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group>
<article-title>Phylogenomic analysis of SARS-CoV-2 genomes from western India reveals unique linked mutations</article-title>
<source>bioRxiv</source>
<year>2020</year>
<comment>2020.07.30.228460</comment>
</element-citation>
</ref>
<ref id="R17">
<label>17</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Banu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Jolly</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Mukherjee</surname>
<given-names>P</given-names>
</name>
<etal/>
</person-group>
<article-title>A distinct phylogenetic cluster of Indian SARS-CoV-2 isolates</article-title>
<source>bioRxiv</source>
<year>2020</year>
<comment>2020.05.31.126136</comment>
</element-citation>
</ref>
<ref id="R18">
<label>18</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Poojary</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Shantaraman</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Jolly</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Scaria</surname>
<given-names>V</given-names>
</name>
</person-group>
<article-title>Computational Protocol for Assembly and Analysis of SARS-nCoV-2 Genomes</article-title>
<source>Research Reports</source>
<year>2020</year>
</element-citation>
</ref>
<ref id="R19">
<label>19</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bolger</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Lohse</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Usadel</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Trimmomatic: a flexible trimmer for Illumina sequence data</article-title>
<source>Bioinformatics</source>
<year>2014</year>
<volume>30</volume>
<issue>15</issue>
<fpage>2114</fpage>
<lpage>2120</lpage>
</element-citation>
</ref>
<ref id="R20">
<label>20</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Langmead</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Salzberg</surname>
<given-names>SL</given-names>
</name>
</person-group>
<article-title>HISAT: a fast spliced aligner with low memory requirements</article-title>
<source>Nat Methods</source>
<year>2015</year>
<volume>12</volume>
<issue>4</issue>
<fpage>357</fpage>
<lpage>360</lpage>
</element-citation>
</ref>
<ref id="R21">
<label>21</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Handsaker</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Wysoker</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group>
<article-title>The Sequence Alignment/Map format and SAMtools</article-title>
<source>Bioinformatics</source>
<year>2009</year>
<volume>25</volume>
<issue>16</issue>
<fpage>2078</fpage>
<lpage>2079</lpage>
</element-citation>
</ref>
<ref id="R22">
<label>22</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koboldt</surname>
<given-names>DC</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Wylie</surname>
<given-names>T</given-names>
</name>
<etal/>
</person-group>
<article-title>VarScan: variant detection in massively parallel sequencing of individual and pooled samples</article-title>
<source>Bioinformatics</source>
<year>2009</year>
<volume>25</volume>
<issue>17</issue>
<fpage>2283</fpage>
<lpage>2285</lpage>
</element-citation>
</ref>
<ref id="R23">
<label>23</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shen</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Le</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>SeqKit: A Cross-Platform and Ultrafast Toolkit for FASTA/Q File Manipulation</article-title>
<source>PLoS One</source>
<year>2016</year>
<volume>11</volume>
<issue>10</issue>
<fpage>e0163962</fpage>
</element-citation>
</ref>
<ref id="R24">
<label>24</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hakonarson</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data</article-title>
<source>Nucleic Acids Res</source>
<year>2010</year>
<volume>38</volume>
<issue>16</issue>
<fpage>e164</fpage>
</element-citation>
</ref>
<ref id="R25">
<label>25</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Page</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Delaney</surname>
<given-names>AJ</given-names>
</name>
<etal/>
</person-group>
<article-title>rapid efficient extraction of SNPs from multi-FASTA alignments</article-title>
<source>Microb Genom</source>
<year>2016</year>
<volume>2</volume>
<issue>4</issue>
<fpage>e000056</fpage>
</element-citation>
</ref>
<ref id="R26">
<label>26</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hadfield</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Megill</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Bell</surname>
<given-names>SM</given-names>
</name>
<etal/>
</person-group>
<article-title>Nextstrain: real-time tracking of pathogen evolution</article-title>
<source>Bioinformatics</source>
<year>2018</year>
<volume>34</volume>
<issue>23</issue>
<fpage>4121</fpage>
<lpage>4123</lpage>
</element-citation>
</ref>
<ref id="R27">
<label>27</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rambaut</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Holmes</surname>
<given-names>EC</given-names>
</name>
<name>
<surname>O'Toole</surname>
<given-names>Á</given-names>
</name>
<etal/>
</person-group>
<article-title>A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology</article-title>
<source>Nat Microbiol</source>
<year>2020</year>
</element-citation>
</ref>
<ref id="R28">
<label>28</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Letunic</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Bork</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Interactive Tree Of Life (iTOL) v4: recent updates and new developments</article-title>
<source>Nucleic Acids Res</source>
<year>2019</year>
<volume>47</volume>
<issue>W1</issue>
<fpage>W256</fpage>
<lpage>W259</lpage>
</element-citation>
</ref>
<ref id="R29">
<label>29</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Katoh</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Toh</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Recent developments in the MAFFT multiple sequence alignment program</article-title>
<source>Brief Bioinform</source>
<year>2008</year>
<volume>9</volume>
<issue>4</issue>
<fpage>286</fpage>
<lpage>298</lpage>
</element-citation>
</ref>
<ref id="R30">
<label>30</label>
<element-citation publication-type="web">
<person-group person-group-type="author">
<name>
<surname>DeMaio</surname>
<given-names>Nicola</given-names>
</name>
<name>
<surname>n_j_loman</surname>
</name>
<name>
<surname>goldman</surname>
</name>
</person-group>
<article-title>Issues with SARS-CoV-2 sequencing data</article-title>
<year>2020</year>
<date-in-citation>cited 2020 Sep 9</date-in-citation>
<comment>Available from: <ext-link ext-link-type="uri" xlink:href="https://virological.org/t/issues-with-sars-cov-2-sequencing-data/473">https://virological.org/t/issues-with-sars-cov-2-sequencing-data/473</ext-link>
</comment>
</element-citation>
</ref>
<ref id="R31">
<label>31</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rozas</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ferrer-Mata</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sánchez-DelBarrio</surname>
<given-names>JC</given-names>
</name>
<etal/>
</person-group>
<article-title>DnaSP 6: DNA Sequence Polymorphism Analysis of Large Data Sets</article-title>
<source>Mol Biol Evol</source>
<year>2017</year>
<volume>34</volume>
<issue>12</issue>
<fpage>3299</fpage>
<lpage>3302</lpage>
</element-citation>
</ref>
<ref id="R32">
<label>32</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Clement</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Posada</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Crandall</surname>
<given-names>KA</given-names>
</name>
</person-group>
<article-title>TCS: a computer program to estimate gene genealogies</article-title>
<source>Mol Ecol</source>
<year>2000</year>
<volume>9</volume>
<issue>10</issue>
<fpage>1657</fpage>
<lpage>1659</lpage>
</element-citation>
</ref>
<ref id="R33">
<label>33</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leigh</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Bryant</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>popart : full-feature software for haplotype network construction</article-title>
<person-group person-group-type="editor">
<name>
<surname>Nakagawa</surname>
<given-names>S</given-names>
</name>
</person-group>
<source>Methods Ecol Evol</source>
<year>2015</year>
<volume>6</volume>
<issue>9</issue>
<fpage>1110</fpage>
<lpage>1116</lpage>
</element-citation>
</ref>
<ref id="R34">
<label>34</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Suchard</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Lemey</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Baele</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Ayres</surname>
<given-names>DL</given-names>
</name>
<name>
<surname>Drummond</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Rambaut</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Bayesian phylogenetic and phylodynamic data integration using BEAST 1.10</article-title>
<source>Virus Evol</source>
<year>2018</year>
<volume>4</volume>
<issue>1</issue>
<fpage>vey016</fpage>
</element-citation>
</ref>
<ref id="R35">
<label>35</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rambaut</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Drummond</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Baele</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Suchard</surname>
<given-names>MA</given-names>
</name>
</person-group>
<article-title>Posterior Summarization in Bayesian Phylogenetics Using Tracer 1.7</article-title>
<source>Syst Biol</source>
<year>2018</year>
<volume>67</volume>
<issue>5</issue>
<fpage>901</fpage>
<lpage>904</lpage>
</element-citation>
</ref>
<ref id="R36">
<label>36</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wallace</surname>
<given-names>RB</given-names>
</name>
<name>
<surname>Shaffer</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Murphy</surname>
<given-names>RF</given-names>
</name>
<name>
<surname>Bonner</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hirose</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Itakura</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Hybridization of synthetic oligodeoxyribonucleotides to phi chi 174 DNA: the effect of single base pair mismatch</article-title>
<source>Nucleic Acids Res</source>
<year>1979</year>
<volume>6</volume>
<issue>11</issue>
<fpage>3543</fpage>
<lpage>3557</lpage>
</element-citation>
</ref>
<ref id="R37">
<label>37</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ng</surname>
<given-names>PC</given-names>
</name>
<name>
<surname>Henikoff</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>SIFT: Predicting amino acid changes that affect protein function</article-title>
<source>Nucleic Acids Res</source>
<year>2003</year>
<volume>31</volume>
<issue>13</issue>
<fpage>3812</fpage>
<lpage>3814</lpage>
</element-citation>
</ref>
<ref id="R38">
<label>38</label>
<element-citation publication-type="journal">
<collab>The UniProt Consortium</collab>
<article-title>UniProt: the universal protein knowledgebase</article-title>
<source>Nucleic Acids Res</source>
<year>2017</year>
<volume>45</volume>
<issue>D1</issue>
<fpage>D158</fpage>
<lpage>D169</lpage>
</element-citation>
</ref>
<ref id="R39">
<label>39</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vita</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Mahajan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Overton</surname>
<given-names>JA</given-names>
</name>
<etal/>
</person-group>
<article-title>The Immune Epitope Database (IEDB): 2018 update</article-title>
<source>Nucleic Acids Res</source>
<year>2019</year>
<volume>47</volume>
<issue>D1</issue>
<fpage>D339</fpage>
<lpage>D343</lpage>
</element-citation>
</ref>
<ref id="R40">
<label>40</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Nie</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group>
<article-title>The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity</article-title>
<source>Cell</source>
<year>2020</year>
<volume>182</volume>
<issue>5</issue>
<fpage>1284</fpage>
<lpage>1294.e9</lpage>
</element-citation>
</ref>
<ref id="R41">
<label>41</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Rafiul Islam</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Nazmul Hoque</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Shaminur Rahman</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group>
<chapter-title>Genome-wide analysis of SARS-CoV-2 virus strains circulating worldwide implicates heterogeneity</chapter-title>
<source>Sci Rep</source>
<publisher-name>Nature Publishing Group</publisher-name>
<year>2020</year>
<volume>10</volume>
<issue>1</issue>
<fpage>1</fpage>
<lpage>9</lpage>
</element-citation>
</ref>
<ref id="R42">
<label>42</label>
<element-citation publication-type="journal">
<collab>COVID-19 Genomics UK (COG-UK) consortiumcontact@cogconsortium.uk</collab>
<article-title>An integrated national scale SARS-CoV-2 genomic surveillance network</article-title>
<source>Lancet Microbe</source>
<year>2020</year>
<volume>1</volume>
<issue>3</issue>
<fpage>e99</fpage>
<lpage>e100</lpage>
</element-citation>
</ref>
<ref id="R43">
<label>43</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alm</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Broberg</surname>
<given-names>EK</given-names>
</name>
<name>
<surname>Connor</surname>
<given-names>T</given-names>
</name>
<etal/>
</person-group>
<article-title>Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020</article-title>
<source>Euro Surveill</source>
<year>2020</year>
<volume>25</volume>
<issue>32</issue>
</element-citation>
</ref>
<ref id="R44">
<label>44</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oude Munnink</surname>
<given-names>BB</given-names>
</name>
<name>
<surname>Nieuwenhuijse</surname>
<given-names>DF</given-names>
</name>
<name>
<surname>Stein</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group>
<article-title>Rapid SARS-CoV-2 whole-genome sequencing and analysis for informed public health decision-making in the Netherlands</article-title>
<source>Nat Med</source>
<year>2020</year>
</element-citation>
</ref>
<ref id="R45">
<label>45</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stefanelli</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Faggioni</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Lo Presti</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group>
<article-title>Whole genome and phylogenetic analysis of two SARS-CoV-2 strains isolated in Italy in January and February 2020: additional clues on multiple introductions and further circulation in Europe</article-title>
<source>Euro Surveill</source>
<year>2020</year>
<volume>25</volume>
<issue>13</issue>
</element-citation>
</ref>
<ref id="R46">
<label>46</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Plessis L</surname>
<given-names>du</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Z</given-names>
</name>
<etal/>
</person-group>
<article-title>Genomic Epidemiology of SARS-CoV-2 in Guangdong Province, China</article-title>
<source>Cell</source>
<year>2020</year>
<volume>181</volume>
<issue>5</issue>
<fpage>997</fpage>
<lpage>1003.e9</lpage>
</element-citation>
</ref>
<ref id="R47">
<label>47</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X</given-names>
</name>
<etal/>
</person-group>
<article-title>Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China</article-title>
<source>Lancet</source>
<year>2020</year>
<volume>395</volume>
<issue>10223</issue>
<fpage>497</fpage>
<lpage>506</lpage>
</element-citation>
</ref>
<ref id="R48">
<label>48</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Jackson</surname>
<given-names>CB</given-names>
</name>
<name>
<surname>Mou</surname>
<given-names>H</given-names>
</name>
<etal/>
</person-group>
<article-title>The D614G mutation in the SARS-CoV-2 spike protein reduces S1 shedding and increases infectivity</article-title>
<source>bioRxiv</source>
<year>2020</year>
</element-citation>
</ref>
<ref id="R49">
<label>49</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>He</surname>
<given-names>C-L</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>Q-Z</given-names>
</name>
<etal/>
</person-group>
<article-title>D614G mutation of SARS-CoV-2 spike protein enhances viral infectivity. Microbiology</article-title>
<source>bioRxiv</source>
<year>2020</year>
<fpage>1620</fpage>
</element-citation>
</ref>
<ref id="R50">
<label>50</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gaurav</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Pandey</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Puvar</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group>
<article-title>Identification of unique mutations in SARS-CoV-2 strains isolated from India suggests its attenuated pathotype</article-title>
<source>bioRxiv</source>
<year>2020</year>
<date-in-citation>cited 2020 Sep 9</date-in-citation>
<comment>2020.06.06.137604</comment>
</element-citation>
</ref>
<ref id="R51">
<label>51</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Young</surname>
<given-names>BE</given-names>
</name>
<name>
<surname>Fong</surname>
<given-names>S-W</given-names>
</name>
<name>
<surname>Chan</surname>
<given-names>Y-H</given-names>
</name>
<etal/>
</person-group>
<article-title>Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the inflammatory response: an observational cohort study</article-title>
<source>Lancet</source>
<year>2020</year>
<volume>396</volume>
<issue>10251</issue>
<fpage>603</fpage>
<lpage>611</lpage>
</element-citation>
</ref>
<ref id="R52">
<label>52</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lamers</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Raj</surname>
<given-names>VS</given-names>
</name>
<name>
<surname>Shafei</surname>
<given-names>M'd</given-names>
</name>
<etal/>
</person-group>
<article-title>Deletion Variants of Middle East Respiratory Syndrome Coronavirus from Humans, Jordan, 2015</article-title>
<source>Emerg Infect Dis</source>
<year>2016</year>
<volume>22</volume>
<issue>4</issue>
<fpage>716</fpage>
<lpage>719</lpage>
</element-citation>
</ref>
<ref id="R53">
<label>53</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>J-R</given-names>
</name>
<name>
<surname>Kuo</surname>
<given-names>C-Y</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>H-Y</given-names>
</name>
<etal/>
</person-group>
<article-title>Newly emerging mutations in the matrix genes of the human influenza A(H1N1)pdm09 and A(H3N2) viruses reduce the detection sensitivity of real-time reverse transcription-PCR</article-title>
<source>J Clin Microbiol</source>
<year>2014</year>
<volume>52</volume>
<issue>1</issue>
<fpage>76</fpage>
<lpage>82</lpage>
</element-citation>
</ref>
<ref id="R54">
<label>54</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Klungthong</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Chinnawirotpisan</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Hussem</surname>
<given-names>K</given-names>
</name>
<etal/>
</person-group>
<article-title>The impact of primer and probe-template mismatches on the sensitivity of pandemic influenza A/H1N1/2009 virus detection by real-time RT-PCR</article-title>
<source>J Clin Virol</source>
<year>2010</year>
<volume>48</volume>
<issue>2</issue>
<fpage>91</fpage>
<lpage>95</lpage>
</element-citation>
</ref>
<ref id="R55">
<label>55</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Won</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group>
<article-title>Development of a Laboratory-safe and Low-cost Detection Protocol for SARS-CoV-2 of the Coronavirus Disease 2019 (COVID-19)</article-title>
<source>Exp Neurobiol</source>
<year>2020</year>
<volume>29</volume>
<issue>2</issue>
<fpage>107</fpage>
<lpage>119</lpage>
</element-citation>
</ref>
<ref id="R56">
<label>56</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khan</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Cheung</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Presence of mismatches between diagnostic PCR assays and coronavirus SARS-CoV-2 genome</article-title>
<source>Royal Society Open Science</source>
<year>2020</year>
<comment>200636</comment>
</element-citation>
</ref>
</ref-list>
</back>
<floats-group>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption>
<p>Schematic overview of the data analysis workflow comprising sequence alignment, variant calling, variant annotation, phylogenetic, and haplotype analysis employed in the study.</p>
</caption>
<graphic xlink:href="EMS94924-f001"/>
</fig>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption>
<p>The mean coverage of the SARS-CoV-2 genomes across the amplicons of the COVIDSeq</p>
</caption>
<graphic xlink:href="EMS94924-f002"/>
</fig>
<fig id="F3" position="float">
<label>Figure 3</label>
<caption>
<p>(A) Distribution of variants across genomes used in the study (B) Comparison of the proportion of the variants represented with their allele frequency across the SARS-CoV-2 genome in datasets includes Kerala (present study), India, and Global (C) Distribution of the genetic context of variants and their functional classification.</p>
</caption>
<graphic xlink:href="EMS94924-f003"/>
</fig>
<fig id="F4" position="float">
<label>Figure 4</label>
<caption>
<p>(A) Phylogenetic map of the 113 genomes sequenced from Kerala (highlighted by blue dots) with respect to the other genomes from India (B) Distribution of the clades and lineages in Kerala. All genomes clustered under the clade A2a (GISAID clade G and GH) while the dominant lineage was B.1. (C) Lineage distribution in Kerala compared to the distribution across India and global populations.</p>
</caption>
<graphic xlink:href="EMS94924-f004"/>
</fig>
<fig id="F5" position="float">
<label>Figure 5</label>
<caption>
<p>Haplotype network of 850 genomes of Indian isolates of SARS-CoV-2 belonging to the A2a clade. The 3 major haplogroups encompassing the genomes from Kerala are designated as K1, K2, and K3.</p>
</caption>
<graphic xlink:href="EMS94924-f005"/>
</fig>
<table-wrap id="T1" position="float" orientation="portrait">
<label>Table 1</label>
<caption>
<p>Summary of novel genetic variants and their frequencies in the dataset</p>
</caption>
<table frame="box" rules="all">
<thead>
<tr>
<th valign="top" align="left">Variant</th>
<th valign="top" align="left">Gene</th>
<th valign="top" align="left">Variant type</th>
<th valign="top" align="left">Classification</th>
<th valign="top" align="left">Amino Acid Change</th>
<th valign="top" align="left">Domain/Functi onal Region</th>
<th valign="top" align="left">Frequency (Kerala N = 179)</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">
<bold>21486T&gt;C</bold>
</td>
<td valign="top" align="left">ORF1b</td>
<td valign="top" align="left">Coding mutation</td>
<td valign="top" align="left">Synonymous SNV</td>
<td valign="top" align="left">S2673S</td>
<td valign="top" align="left">NA</td>
<td valign="top" align="left">4(2.235%)</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>23719T&gt;C</bold>
</td>
<td valign="top" align="left">S</td>
<td valign="top" align="left">Coding mutation</td>
<td valign="top" align="left">Synonymous SNV</td>
<td valign="top" align="left">T719T</td>
<td valign="top" align="left">NA</td>
<td valign="top" align="left">2(1.117%)</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>25281G&gt;A</bold>
</td>
<td valign="top" align="left">S</td>
<td valign="top" align="left">Coding mutation</td>
<td valign="top" align="left">Non-Synonymous SNV</td>
<td valign="top" align="left">C1240Y</td>
<td valign="top" align="left">NA</td>
<td valign="top" align="left">1(0.559%)</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>27643C&gt;A</bold>
</td>
<td valign="top" align="left">ORF7a</td>
<td valign="top" align="left">Coding mutation</td>
<td valign="top" align="left">Non-Synonymous SNV</td>
<td valign="top" align="left">P84T</td>
<td valign="top" align="left">NA</td>
<td valign="top" align="left">5(2.793%)</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="T2" position="float" orientation="portrait">
<label>Table 2</label>
<caption>
<p>Summary of variants mapping to diagnostic RT-PCR primers or probes</p>
</caption>
<table frame="box" rules="all">
<thead>
<tr>
<th valign="top" align="left">Variant</th>
<th valign="top" align="left">Gene</th>
<th valign="top" align="left">Primer/Probe Name</th>
<th valign="top" align="left">Primer / Probe Sequence Reference Sequence Variant is Underlined</th>
<th valign="top" align="left">Tm With Ref/With Variant</th>
<th valign="top" align="left">No of genomes with variant N=179 (Freq)</th>
<th valign="top" align="left">Freq in Global Dataset N=32286</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">
<bold>14120 C&gt;T</bold>
</td>
<td valign="top" align="left">ORF1b</td>
<td valign="top" align="left">SARS-CoV-2_ IBS_RdRP3_R</td>
<td valign="top" align="left">3'-ACTACCTGGCGTGGTTTGTA-5'<break/>5'-TGATGGA<bold>
<underline>T</underline>
</bold>CGCACCAAACAT-3'</td>
<td valign="top" align="left">51.8 / 49.7</td>
<td valign="top" align="left">1 (0.559%)</td>
<td valign="top" align="left">36(0.112%)</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>22444 C&gt;T</bold>
</td>
<td valign="top" align="left">S</td>
<td valign="top" align="left">SARS-CoV-2_ IBS_S2_R</td>
<td valign="top" align="left">3'-AGGGTCAAGTGCACAGTCTA-5'<break/>5'-TCC<bold>
<underline>T</underline>
</bold>AGTTCACGTGTCAGAT-3'</td>
<td valign="top" align="left">51.8 / 49.7</td>
<td valign="top" align="left">8 (4.469%)</td>
<td valign="top" align="left">372(1.152%)</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>26367 G&gt;C</bold>
</td>
<td valign="top" align="left">E</td>
<td valign="top" align="left">SARS-CoV-2_ IBS_E2_R</td>
<td valign="top" align="left">3'-AGCAGTACGCACACAATCG-5'<break/>5'-TCGTCAT<bold>
<underline>C</underline>
</bold>CGTGTGTTAGC-3'</td>
<td valign="top" align="left">51.1 / 49.7</td>
<td valign="top" align="left">2 (1.117%)</td>
<td valign="top" align="left">6(0.019%)</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>28854 C&gt;T</bold>
</td>
<td valign="top" align="left">N</td>
<td valign="top" align="left">SARS-CoV-2_ IBS_N2_R</td>
<td valign="top" align="left">3'-TGAACTGTTGCGACTACGTG-5'<break/>5'-A<bold>
<underline>T</underline>
</bold>TTGACAACGCTGATGCAC-3'</td>
<td valign="top" align="left">51.8 / 49.7</td>
<td valign="top" align="left">6 (3.352%)</td>
<td valign="top" align="left">1180(3.655%)</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>28899 G&gt;T</bold>
</td>
<td valign="top" align="left">N</td>
<td valign="top" align="left">2019-nCoV-N FP</td>
<td valign="top" align="left">5'-GGGGAACTTCTCCTGCTAGAAT-3 '<break/>3'-CCCCTTGAAGAGGAAGAT<bold>
<underline>A</underline>
</bold>TTA-5 '</td>
<td valign="top" align="left">54.8 / 51.1</td>
<td valign="top" align="left">2 (1.117%)</td>
<td valign="top" align="left">95(0.294%)</td>
</tr>
</tbody>
</table>
</table-wrap>
</floats-group>
</article>
